CrowdStrike (NASDAQ:CRWD – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Canaccord Genuity Group in a report issued on Monday, Benzinga reports. They currently have a $330.00 price target on the stock. Canaccord Genuity Group’s target price points to a potential upside of 19.93% from the company’s current price.
Several other research analysts have also issued reports on the company. Argus lowered their target price on CrowdStrike from $400.00 to $325.00 and set a “buy” rating for the company in a research report on Friday, August 30th. Stifel Nicolaus lowered their target price on CrowdStrike from $400.00 to $300.00 and set a “buy” rating for the company in a research report on Friday, August 9th. Evercore ISI lowered their target price on CrowdStrike from $350.00 to $325.00 and set an “outperform” rating for the company in a research report on Tuesday, July 30th. Rosenblatt Securities reaffirmed a “buy” rating and set a $325.00 target price on shares of CrowdStrike in a research report on Thursday, September 19th. Finally, Royal Bank of Canada lowered their target price on CrowdStrike from $345.00 to $335.00 and set an “outperform” rating for the company in a research report on Thursday, August 29th. One analyst has rated the stock with a sell rating, five have given a hold rating, thirty-three have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $326.50.
Check Out Our Latest Research Report on CRWD
CrowdStrike Price Performance
CrowdStrike (NASDAQ:CRWD – Get Free Report) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.07. The business had revenue of $963.87 million for the quarter, compared to the consensus estimate of $958.27 million. CrowdStrike had a return on equity of 8.44% and a net margin of 4.84%. The firm’s quarterly revenue was up 31.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.06 earnings per share. Equities research analysts predict that CrowdStrike will post 0.53 earnings per share for the current year.
Insider Activity at CrowdStrike
In related news, CFO Burt W. Podbere sold 11,178 shares of the stock in a transaction that occurred on Monday, September 23rd. The shares were sold at an average price of $297.47, for a total transaction of $3,325,119.66. Following the completion of the sale, the chief financial officer now owns 286,472 shares of the company’s stock, valued at $85,216,825.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, insider Shawn Henry sold 4,000 shares of the stock in a transaction that occurred on Monday, July 15th. The shares were sold at an average price of $371.32, for a total transaction of $1,485,280.00. Following the completion of the sale, the insider now owns 183,091 shares of the company’s stock, valued at $67,985,350.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Burt W. Podbere sold 11,178 shares of the stock in a transaction that occurred on Monday, September 23rd. The shares were sold at an average price of $297.47, for a total transaction of $3,325,119.66. Following the sale, the chief financial officer now directly owns 286,472 shares of the company’s stock, valued at approximately $85,216,825.84. The disclosure for this sale can be found here. Insiders sold 96,962 shares of company stock valued at $28,774,798 over the last 90 days. Insiders own 4.34% of the company’s stock.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in CRWD. Evoke Wealth LLC raised its holdings in shares of CrowdStrike by 4.3% in the fourth quarter. Evoke Wealth LLC now owns 1,283 shares of the company’s stock worth $328,000 after buying an additional 53 shares during the last quarter. Dorsey & Whitney Trust CO LLC purchased a new position in shares of CrowdStrike in the fourth quarter worth $286,000. Brown Brothers Harriman & Co. raised its holdings in shares of CrowdStrike by 347.1% in the fourth quarter. Brown Brothers Harriman & Co. now owns 626 shares of the company’s stock worth $160,000 after buying an additional 486 shares during the last quarter. FinTrust Capital Advisors LLC raised its holdings in shares of CrowdStrike by 673.7% in the fourth quarter. FinTrust Capital Advisors LLC now owns 147 shares of the company’s stock worth $38,000 after buying an additional 128 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC raised its holdings in shares of CrowdStrike by 16.0% in the fourth quarter. Campbell & CO Investment Adviser LLC now owns 5,883 shares of the company’s stock worth $1,502,000 after buying an additional 812 shares during the last quarter. Hedge funds and other institutional investors own 71.16% of the company’s stock.
CrowdStrike Company Profile
CrowdStrike Holdings, Inc provides cybersecurity solutions in the United States and internationally. Its unified platform offers cloud-delivered protection of endpoints, cloud workloads, identity, and data. The company offers corporate endpoint and cloud workload security, managed security, security and vulnerability management, IT operations management, identity protection, SIEM and log management, threat intelligence, data protection, security orchestration, automation and response and AI powered workflow automation, and securing generative AI workload services.
Further Reading
- Five stocks we like better than CrowdStrike
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What Are Trending Stocks? Trending Stocks Explained
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Comparing and Trading High PE Ratio Stocks
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for CrowdStrike Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CrowdStrike and related companies with MarketBeat.com's FREE daily email newsletter.